Brian Yoo is an experienced clinical science professional with a strong background in hematology and oncology. Currently serving as the Director of Clinical Science at Schrödinger since November 2021, Brian leads the clinical development of the MALT-1 inhibitor SGR-1505 in phase 1 trials, contributing to clinical strategy, data analysis, and regulatory interactions. Prior to this, Brian held roles as Associate Director at Schrödinger and Clinical Scientist at Bristol Myers Squibb, where responsibilities included protocol development and trial execution for hematologic disorders. Additionally, experience includes a position at Siemens Healthineers focusing on clinical validation of prostate cancer assays, and as a Clinical Trials Associate at Northwell Health managing clinical trial operations. Brian holds a Bachelor of Arts in Chemistry and Economics from Cornell University.
This person is not in any teams
This person is not in any offices